SCHEMBL486824

SCHEMBL486824

O=C(O)c1c(Cl)ccc(Cl)c1C(=O)O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.71
ALDH1A1 P00352 5/20 0.60
KDM4E B2RXH2 2/20 0.60
HSD17B10 Q99714 1/20 0.60
TSHR P16473 5/20 0.50
TP53 P04637 2/20 0.48
PBRM1 Q86U86 1/20 0.44
ALOX15 P16050 1/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43
SRD5A2 P31213 1/20 0.43
CASP1 P29466 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
FEN1 P39748 1/20 0.41
FABP3 P05413 1/20 0.41
FABP4 P15090 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28737172 0.97 DPP4 (0.68) DPP4ALDH1A1KDM4EHSD17B10TSHR
SCHEMBL16702731 0.97 DPP4 (0.68) DPP4ALDH1A1KDM4EHSD17B10TSHR
SCHEMBL9681770 0.87 DPP4 (0.58) DPP4ALDH1A1KDM4EHSD17B10TSHR
SCHEMBL8330035 0.87 DPP4 (0.58) DPP4ALDH1A1KDM4EHSD17B10TSHR
SCHEMBL9450686 0.87 DPP4 (0.58) DPP4ALDH1A1KDM4EHSD17B10TSHR
SCHEMBL10771891 0.87 DPP4 (0.58) DPP4ALDH1A1KDM4EHSD17B10TSHR
2,3,6-Trichlorobenzoic Acid SCHEMBL29365114 0.86 DPP4 (0.62) DPP4ALDH1A1KDM4EHSD17B10TSHR
2,3,6-Trichlorobenzoic Acid SCHEMBL117071 0.86 DPP4 (0.62) DPP4ALDH1A1KDM4EHSD17B10TSHR
SCHEMBL9695014 0.85 DPP4 (0.56) DPP4ALDH1A1KDM4EHSD17B10TSHR
SCHEMBL21750029 0.85 DPP4 (0.56) DPP4ALDH1A1KDM4EHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 564 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4608925-B1 METHOD FOR PRODUCING A LOW TEMPERATURE CURABLE POWDER COATING COMPOSITION AND LOW TEMPERATURE CURABLE POWDER COATING COMPOSITION OBTAINABLE BY SUCH METHOD PULVER KIMYA SAN VE TIC A S (TR) 2026-02-04 EP claimed
EP-4608925-A1 METHOD FOR PRODUCING A LOW TEMPERATURE CURABLE POWDER COATING COMPOSITION AND LOW TEMPERATURE CURABLE POWDER COATING COMPOSITION OBTAINABLE BY SUCH METHOD Pulver Kimya San. ve Tic. A.S. (TR) 2025-09-03 EP claimed
WO-2024088676-A1 METHOD FOR PRODUCING A LOW TEMPERATURE CURABLE POWDER COATING COMPOSITION AND LOW TEMPERATURE CURABLE POWDER COATING COMPOSITION OBTAINABLE BY SUCH METHOD PULVER KIMYA SAN. VE TIC. A.S. (TR) 2024-05-02 WO claimed
EP-4361227-A1 METHOD FOR PRODUCING A LOW TEMPERATURE CURABLE POWDER COATING COMPOSITION AND LOW TEMPERATURE CURABLE POWDER COATING COMPOSITION OBTAINABLE BY SUCH METHOD Pulver Kimya San. ve Tic. A.S. (TR) 2024-05-01 EP claimed
US-20140031289-A1 POLY(ORGANOPHOSPHAZENE) CONTAINING DEGRADATION CONTROLLABLE IONIC GROUP, PREPARATION METHOD THEREOF AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2014-01-30 US claimed
EP-1208134-A1 A PROCESS FOR THE PREPARATION OF A CONDENSATION POLYMER DSM N.V. (NL) 2002-05-29 EP claimed
WO-2001016213-A1 A PROCESS FOR THE PREPARATION OF A CONDENSATION POLYMER DSM N.V. (NL) 2001-03-08 WO claimed
EP-1081176-A1 Process for the preparation of a condensation polymer DSM N.V. (NL) 2001-03-07 EP claimed
US-4981999-A Selective removal of chlorine from chlorophthalic compounds OCCIDENTAL CHEMICAL CORPORATION (US) 1991-01-01 US claimed
EP-4347683-B1 CURABLE PHOTOCHROMIC COMPOSITION TRANSITIONS OPTICAL LTD (IE) 2026-05-06 EP disclosed
EP-4688904-A1 LOW TEMPERATURE CURABLE ONE COMPONENT EPOXY COMPOSITIONS CONTAINING RESIN-BLOCKED UREA CURATIVES Evonik Operations GmbH (DE) 2026-02-11 EP disclosed
EP-4608925-B1 METHOD FOR PRODUCING A LOW TEMPERATURE CURABLE POWDER COATING COMPOSITION AND LOW TEMPERATURE CURABLE POWDER COATING COMPOSITION OBTAINABLE BY SUCH METHOD PULVER KIMYA SAN VE TIC A S (TR) 2026-02-04 EP disclosed
US-12503543-B2 Curable photochromic polycarbodiimide compositions TRANSITIONS OPTICAL, LTD. (IE) 2025-12-23 US disclosed
EP-4034610-B1 DIHYDROQUINOLINE PHOTOCHROMIC COMPOUNDS TRANSITIONS OPTICAL LTD (IE) 2025-09-10 EP disclosed
US-4112012-A Pulverulent coating agents BAYER AKTIENGESELLSCHAFT (DE) 1978-09-05 US disclosed
US-4100095-A BORIC ACID THE PROCTER & GAMBLE COMPANY (US) 1978-07-11 US disclosed
US-4002642-A Process for the preparation of polyhalo copper phthalocyanines HOECHST AKTIENGESELLSCHAFT (DT) 1977-01-11 US disclosed
US-3966836-A POLYEPOXIDES, POLYESTERS BAYER AKTIENGESELLSCHAFT (DT) 1976-06-29 US disclosed
US-3947477-A Process for the preparation of aminohydroxyanthraquinones BAYER AKTIENGESELLSCHAFT (DT) 1976-03-30 US disclosed
US-3932358-A CROSSLINKING BAYER AKTIENGESELLSCHAFT (DT) 1976-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140031289-A1 POLY(ORGANOPHOSPHAZENE) CONTAINING DEGRADATION CONTROLLABLE IONIC GROUP, PREPARATION METHOD THEREOF AND USE THEREOF PHOSPHO1, PLCB3, INPP5D DPP4 612/4885ALDH1A1 4053/4885KDM4E 1770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.